1-3 of 3
Puthen V. Jithesh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting Treatment-Resistant Breast Cancer Stem Cells with FKBPL and Its Peptide Derivative, AD-01, via the CD44 Pathway

Lana McClements, Anita Yakkundi, Angelos Papaspyropoulos, Hannah Harrison, Matthew P. Ablett, Puthen V. Jithesh, Hayley D. McKeen, Rachel Bennett, Christopher Donley, Adrien Kissenpfennig, Stuart McIntosh, Helen O. McCarthy, Eric O'Neill, Robert B. Clarke, Tracy Robson
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (14): 3881–3893.
https://doi.org/10.1158/1078-0432.CCR-13-0595
Published: 15 July 2013
View article titled, Targeting Treatment-Resistant Breast Cancer Stem Cells with FKBPL and Its Peptide Derivative, AD-01, via the CD44 Pathway
Open the PDF for Targeting Treatment-Resistant Breast Cancer Stem Cells with FKBPL and Its Peptide Derivative, AD-01, via the CD44 Pathway in another window
Includes: Supplementary data
Journal Articles

Identification of Galanin and Its Receptor GalR1 as Novel Determinants of Resistance to Chemotherapy and Potential Biomarkers in Colorectal Cancer

Leanne Stevenson, Wendy L. Allen, Richard Turkington, Puthen V. Jithesh, Irina Proutski, Gail Stewart, Heinz-Josef Lenz, Sandra Van Schaeybroeck, Daniel B. Longley, Patrick G. Johnston
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (19): 5412–5426.
https://doi.org/10.1158/1078-0432.CCR-12-1780
Published: 30 September 2012
View article titled, Identification of Galanin and Its Receptor GalR1 as Novel Determinants of Resistance to Chemotherapy and Potential Biomarkers in Colorectal Cancer
Open the PDF for Identification of Galanin and Its Receptor GalR1 as Novel Determinants of Resistance to Chemotherapy and Potential Biomarkers in Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Clinical Determinants of Response to Irinotecan-Based Therapy Derived from Cell Line Models

Wendy L. Allen, Vicky M. Coyle, Puthen V. Jithesh, Irina Proutski, Leanne Stevenson, Cathy Fenning, Daniel B. Longley, Richard H. Wilson, Michael Gordon, Heinz-Josef Lenz, Patrick G. Johnston
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (20): 6647–6655.
https://doi.org/10.1158/1078-0432.CCR-08-0452
Published: 16 October 2008
View article titled, Clinical Determinants of Response to Irinotecan-Based Therapy Derived from Cell Line Models
Open the PDF for Clinical Determinants of Response to Irinotecan-Based Therapy Derived from Cell Line Models in another window
Includes: Supplementary data